Podcasts about Mk

Utah Governor Spencer Cox confirms Charlie Kirk's alleged assassin was steeped in leftist ideology as investigators uncover new details about his personal life. Erika Kirk vows her husband's mission will live on, declaring his assassination only strengthens the movement he built. The accused killer of Iryna Zarutska is sent for a psychiatric evaluation in North Carolina that could determine whether he ever stands trial. Riverbend Ranch: Visit https://riverbendranch.com/ | Use promo code MEGYN for $20 off your first order.Lean: Visit https://TakeLean.com & use code MK for 20% off Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Подкаст «Top Club Chart» выходит каждый понедельник.  Подпишись на нас в Apple Podcasts, Castbox и SoundStream, чтобы не пропустить новые эпизоды.  Комментарии, вопросы и пожелания отправляй на t.bodrov@europaplus.ru  Ведущий и продюсер: Тимур Бодров Саундпродюсер: Ярослав Чернобров Редактор подкаста: Дарья Бельдий 1. Serve Cold & Grigoré x Jaguar Jaguar - LOW (25 место) 2. MK ft. CHRYSTAL - Dior (24 место) 3. Kolter - Liquor Store (23 место) 4. Alaia & Gallo - Lipstick (22 место) 5. Disco Lines & Tinashe - No Broke Boys (21 место) 6. 3 Are Legend & Timbaland & W&W - Cry Me A River (20 место) 7. Alexander Popov & Terry Golden - Obsession (19 место) 8. Odd Mob & OMNOM pres. HYPERBEAM - System (18 место) 9. RITN - Down (РЕЗИДЕНЦИЯ) 10. Paul Oakenfold & Goom Gum - The House Of House (17 место) 11. Jordan Peak - Front 2 Back (16 место) 12. Fantomel & Kate Linn - Dame Un Grrr (PROVI Remix) (15 место) 13. Argy & MEDUZA ft. PollyAnna - Melodia (14 место) 14. Toman - Verano en NY (13 место) 15. Empire Of The Sun - Walking On A Dream (BLOND:ISH Remix) (12 место) 16. DumitrEscu - Sitting In The Sun (Walking In The Rain) (11 место) 17. FISHER & bbyclose - Blackberries (10 место) 18. Samm (BE) - Body Language (9 место) 19. Calvin Harris & D.O.D - Sweet Nothing (2025 Edit) (8 место) 20. Chris Lorenzo & Max Styler & Audio Bullys - London's On Fire (7 место) 21. The Chemical Brothers - Galvanize (Chris Lake Remix) (6 место) 22. Da Hool - Meet Her At The Love Parade (ХИТ ВСЕХ ВРЕМЁН) 23. Sebastian Ingrosso ft. Céline Dion - A New Day (5 место) 24. Skytech & Vion Konger - Everybody's Free (To Feel Good) (4 место) 25. Jonas Blue & Malive - Edge Of Desire (3 место) 26. Mau P - TESLA (2 место) 27. Going Deeper, Wicks, Judgemxnt - Safe With Me (ПЕРСПЕКТИВА) 28. CamelPhat & Elderbrook - Cola (ARTBAT Remix) (1 место)

A New Era Is Beginning In Your Life | നിങ്ങളുടെ ജീവിതത്തിൽ ഒരു പുതിയ യുഗം ആരംഭിക്കുന്നു | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1711 | 15 Sep 2025

Megyn Kelly is joined by Charlie Sheen, author of "The Book of Sheen," to talk about getting sober, how he mended his relationship with his father Martin and brother Emilio, getting to work with his dad in "Wall Street," that wild moment in 2011 when he was fired at the height of his career for erratic behavior, the potential enablers around him during that time, his early career successes, being the son of Martin Sheen, his breakout role in "Ferris Bueller," turning down the lead in "Karate Kid," his powerful performance in "Platoon," his longtime friendship with Nicholas Cage, his past experience with Matthew Perry, revelations about past relationships, and more.More from Sheen: https://www.charliesheenbook.com/ Done with Debt: https://www.DoneWithDebt.com & tell them Megyn Kelly sent you!Masa Chips: Get 25% off your first order | Use code MK at https://MASAChips.com/MKBirch Gold: Text MK to 989898 and get your free info kit on goldFollow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShowFind out more information at:https://www.devilmaycaremedia.com/megynkellyshow  

Nothing Shall Harm Me! | ഒന്നും എനിക്കു ദോഷം വരുത്തുകയില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1710 | 13 Sep 2025

Megyn Kelly begins the show by discussing the breaking news that the alleged Charlie Kirk assassin has been taken into custody, the details about the 22-year-old suspect, the truth about the "anti-fascist" and bizarre internet memes including about furries engraved on his ammo, what may have led to the radicalization of Charlie Kirk's alleged assassin, the possible role of college in shaping his ideology, how his father recognized him and convinced him to turn himself into authorities, whether the alleged Charlie Kirk assassin will face the death penalty in Utah, Erika and Charlie Kirk's beautiful marriage and relationship, how they met through Turning Point USA, the strong Christian foundation of their relationship, members of the media for using Kirk's assassination to smear conservatives, and more.PrizePicks: Download the PrizePicks app today and use code MEGYN to get $50 in lineups after you play your first $5 lineup! Visit https://prizepicks.onelink.me/LME0/MEGYNMasa Chips: Get 25% off your first order | Use code MK at https://MASAChips.com/MKJust Thrive: Visit https://justthrivehealth.com/discount/Megyn and use code MEGYN to save 20% sitewideChapter: For free and unbiased Medicare help, dial 276-334-2273 or go to https://askchapter.org/kelly Disclaimer: Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options.Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow

One hour of hand picked selections from house music maestro and remix extraordinaire, MK! Expect fresh cuts and upcoming releases from himself, his record label, favourite producers and DJ friends. Delving in to house and techno, new and old, as well as showcasing his Track Of The Month, AREA10 Fire, From The Vault and exclusive Guest Mix each month. This is AREA10 ON AIR! 1) Castion & Sergiodnine - Wanna Come (Extended Mix)2) Arielle Free x Tristan Henry - Mind Body & Soul (Extended Mix)3) Seumas Norv - Through you (Ciava Remix)4) Joshwa - Wildflower (Extended Mix)5) Mousse T., Wankelmut, Francesco Yates - Some Kinda Feeling (Extended Mix)6) Trallez - Ladies & Gentlemen (Extended Mix)7) Paul Harris - Words (Extended Mix)8) Jamie Jones & Baby Rose - Rolling Thunder (JJ's Playa Extended Mix)9) Juan Diazo - Conditions (Extended Mix)10) Castion - Fall Out The Beat (Extended)11) Michael Bibi - Front & Back Seat (Extended Mix)12) Lucas & Steve - Push The Feeling On (Extended Mix)13) FS Green - TTU Feat. Naken (Extended)14) Justin Curoe - Feeling Low (Extended Mix)

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

Things go from weird to awful in this season of AHS, while MK talks being deprived of reality TV and British Humor, and Courtney talks books and the upcoming spooky season!

No Mountain Shall Stand Before Me! | ഒരു പർവതവും എൻ്റെ മുന്നിൽ നിൽക്കില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1709 | 12 Sep 2025

09. bis 13. September 2025 – 23. Woche im JahreskreisChristine Hubka macht sich Gedanken zu den Evangelien der Wochentage. Sie ist evangelische Pfarrerin im Ruhestand, Gefängnisseelsorgerin und Autorin. Unter ihren Büchern sind immer wieder auch Kinderbücher. Z.B.: „Und doch sind alle Äpfel rund… Was Judentum, Christentum und Islam gemeinsam haben. Eine besondere Familiengeschichte.“ Erschienen im Tyrolia-Verlag.Montag, 08. September 2025Wir Gottgewollten.Röm 8, 28-30Dienstag, 09. September 2025Taufkraft.Kol 2, 6-15Mittwoch, 10. September 2025Die menschliche Bibel.Lk 6, 20-26Donnerstag, 11. September 2025Biblisch lieben.Kol 3, 12-17Freitag, 12. September 2025Die Lebensgeschichte als Geschenk.1 Tim 1, 1-2.12-14Samstag, 13. September 2025Warum wenig viel ist.Mk 4, 1-20Einen Link zu den Texten finden Sie hier.

Megyn Kelly opens the show by remembering the legacy of Charlie Kirk, new reporting about "trans" phrases found on the gun ammunition used to shoot Kirk, the latest information about the search for the assassin, and more. Then Donald Trump Jr., EVP of the Trump Organization, joins to reflect on the loss of his close friend Charlie Kirk, what Kirk meant to President Trump, the legacy he leaves behind, the very real dangers Charlie Kirk faced in the work he did, some on the left like Jen Psaki attacking Trump for his response to the Kirk assassination, and more. Then Benny Johnson, host of "The Benny Show,” joins to discuss how we must honor Charlie Kirk now, how the Turning Point organization and those around him are holding up, what Kirk's haters don't understand about his grace and kindness, and more. Then Tucker Carlson, host of "The Tucker Carlson Show," comes on to discuss the kindness and grace Charlie showed to everyone, the vile comments from those expressing satisfaction over his assassination, the dark state we are living in now, Charlie's legacy of faith and patriotism, the impact he leaves behind, the danger those in the political spotlight face, and more. Carlson: http://tuckercarlson.com/Trump: https://rumble.com/c/DonaldJTrumpJrJohnson: https://www.youtube.com/@bennyjohnson/ Riverbend Ranch: Visit https://riverbendranch.com/ | Use promo code MEGYN for $20 off your first order.Just Thrive: Visit https://justthrivehealth.com/discount/Megyn and use code MEGYN to save 20% sitewideSelectQuote: Life insurance is never cheaper than it is today. Get the right life insurance for YOU, for LESS, and save more than fifty percent at https://selectquote.com/megynFirecracker Farm: Visit https://firecracker.FARM & enter code MK at checkout for a special discount!  Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow 

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

No Works Of The Devil Shall Destroy Me! | പിശാചിൻ്റെ ഒരു പ്രവൃത്തിക്കും എന്നെ നശിപ്പിക്കാനാവില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1708 | 11 Sep 2025

09. bis 13. September 2025 – 23. Woche im JahreskreisChristine Hubka macht sich Gedanken zu den Evangelien der Wochentage. Sie ist evangelische Pfarrerin im Ruhestand, Gefängnisseelsorgerin und Autorin. Unter ihren Büchern sind immer wieder auch Kinderbücher. Z.B.: „Und doch sind alle Äpfel rund… Was Judentum, Christentum und Islam gemeinsam haben. Eine besondere Familiengeschichte.“ Erschienen im Tyrolia-Verlag.Montag, 08. September 2025Wir Gottgewollten.Röm 8, 28-30Dienstag, 09. September 2025Taufkraft.Kol 2, 6-15Mittwoch, 10. September 2025Die menschliche Bibel.Lk 6, 20-26Donnerstag, 11. September 2025Biblisch lieben.Kol 3, 12-17Freitag, 12. September 2025Die Lebensgeschichte als Geschenk.1 Tim 1, 1-2.12-14Samstag, 13. September 2025Warum wenig viel ist.Mk 4, 1-20Einen Link zu den Texten finden Sie hier.

Federal prosecutors file a murder charge against the repeat offender accused of stabbing 23-year-old Iryna Zarutska to death on a Charlotte light-rail train. Mayoral front-runner Zohran Mamdani doubles down on his support for abolishing New York City's gang database, a move law enforcement says would undercut crime-fighting tools. The Bureau of Labor Statistics issues the largest annual jobs revision in history, showing the truth about Biden's economy last year. New filings reveal Alexandria Ocasio-Cortez's campaign spent thousands of small-dollar donations on luxury hotels during her “Fighting Oligarchy” tour. Cozy Earth: Luxury shouldn't be out of reach. Go to https://cozyearth.com/MEGYNfor up to 40% off. Lean: Visit https://TakeLean.com & use code MK for 20% off

Megyn Kelly opens her show by playing and reacting to the full Charlotte stabbing video that was put out, explains why we must all watch the horror, breaks down why this is a “tipping point,” and more. Then The Daily Wire reporter Megan Basham, "When Race Trumps Merit" author Heather Mac Donald, and "Toxic Empathy" author Allie Beth Stuckey join to discuss why the Charlotte stabbing of Iryna Zarutska should serve as a “tipping point,” the realities of interracial crime, terrible reactions from the media and city leaders, why elites avoid discussing the Charlotte stabbing racial elements, systemic and legal issues that allow repeat offenders to remain on the streets, why mentally ill criminals should not be allowed to roam the streets, and more. Then Mike Solana, editor-in-chief of Pirate Wires, joins to talk about the first excerpt from Kamala Harris' new book, her non-stop complaints about everything, her criticisms of Joe Biden and his administration, Kamala's claim she actually helped fix the immigration crisis, her refusal to actually answer the question of who was running the country for four years, the reaction to the book so far from the left, Morning Joe's history of Biden lies, and more. Birch Gold: Text MK to 989898 and get your free info kit on goldFirecracker Farm: Visit https://firecracker.FARM & enter code MK at checkout for a special discount!Byrna: Go to https://Byrna.com or your local Sportsman's Warehouse today.PrizePicks: Download the PrizePicks app today and use code MEGYN to get $50 in lineups after you play your first $5 lineup! Visit https://prizepicks.onelink.me/LME0/MEGYN  Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

No Tongue Shall Cause Any Damage To Me! | ഒരു നാവും എന്നെ നശിപ്പിക്കയില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1707 | 10 Sep 2025

09. bis 13. September 2025 – 23. Woche im JahreskreisChristine Hubka macht sich Gedanken zu den Evangelien der Wochentage. Sie ist evangelische Pfarrerin im Ruhestand, Gefängnisseelsorgerin und Autorin. Unter ihren Büchern sind immer wieder auch Kinderbücher. Z.B.: „Und doch sind alle Äpfel rund… Was Judentum, Christentum und Islam gemeinsam haben. Eine besondere Familiengeschichte.“ Erschienen im Tyrolia-Verlag.Montag, 08. September 2025Wir Gottgewollten.Röm 8, 28-30Dienstag, 09. September 2025Taufkraft.Kol 2, 6-15Mittwoch, 10. September 2025Die menschliche Bibel.Lk 6, 20-26Donnerstag, 11. September 2025Biblisch lieben.Kol 3, 12-17Freitag, 12. September 2025Die Lebensgeschichte als Geschenk.1 Tim 1, 1-2.12-14Samstag, 13. September 2025Warum wenig viel ist.Mk 4, 1-20Einen Link zu den Texten finden Sie hier.

The Supreme Court delivers a victory for Trump's immigration agenda, reinstating ICE's authority to conduct roving patrols in Los Angeles. Internal emails reveal DOJ dissent over Biden's last-minute pardons as the Oversight Committee nears a final report on the autopen. Jury selection begins in the trial of Ryan Routh, accused of attempting to assassinate President Trump at his Florida golf course. Treasury Secretary Scott Bessent reportedly challenged Housing chief Bill Pulte to a fight at a private DC dinner. Get 20% Off with code MK at TakeLean.comGo to COZYEARTH.com | Use code MEGYN & save up to 40% off on Cozy Earth!

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

This series is from our Adult Getaway Conference.Pastor Doug Anderson is profoundly influenced by his early years as an “MK” (missionary kid) in Haiti. Shortly after college, Doug and his wife, Dawn, sensed God's call to return to the mission field to plant a church in Haiti. It was during this time that Doug also served as administrator of UFM Medical Ministries and as an MK educator! Following his time in Haiti, Pastor Doug served as senior pastor of three different Evangelical Free Churches in New Jersey, North Dakota, and Wisconsin. More recently, TEAM, a global missions organization, asked Doug to join their ministry as pastor to their global missionary force. Currently, Pastor Doug serves as the interim senior pastor at a church in Florida! Having a passion for discipleship, Doug developed Walking with Jesus, a daily devotional that reflects on a portion of God's Word. Walking with Jesus is available in both print and audio and has reached over 1,200 cities in 71 countries, including regions closed to the Gospel and Christian missionaries! Pastor Doug and Dawn currently live in Leesburg, Florida. Their only child, April, met and married her husband at Moody Bible Institute. They now serve as third-generation missionaries with their five girls in Dakar, Senegal, West Africa. They have five little girls!

Joe Sheehan, The Joe Sheehan Newsletter joins Ian to give an honest perception of the Mariners right now and where their chances still lie in the AL West. He also talks about Julio Rodriguez and the undue criticism he's received. He's gone back to being underrated. Joe says he's the best centerfielder in baseball. How historic is Cal Raleigh's season? The Cougar Roundtable with Alex Brink and Mkristo Bruce! The Cougars have shown growth from week 1 to week 2, so what have we learned about them? Brink and MK break down the pluses we saw from the weekend. MK and Brink continue with a preview of the Cougs first road game under Jimmy Rogers as they face North Texas under former WSU UC Eric Morris. John Lund, Unleashed! Lund takes his swats at Seattle after week one against the 49ers. He gives us the Santa Clara side of the game against the Seahawks and why they were able to take the first game from Seattle. He tells us what he's seeing across the NFC this season and what surprised him...and what didn't. FACT OR FICTION! Crosstalk with Softy!See omnystudio.com/listener for privacy information.

No Weapon Shall Prevail Against Me! | എനിക്കെതിരെ യാതൊരു ആയുധവും ഫലിക്കയില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1706 | 09 Sep 2025

09. bis 13. September 2025 – 23. Woche im JahreskreisChristine Hubka macht sich Gedanken zu den Evangelien der Wochentage. Sie ist evangelische Pfarrerin im Ruhestand, Gefängnisseelsorgerin und Autorin. Unter ihren Büchern sind immer wieder auch Kinderbücher. Z.B.: „Und doch sind alle Äpfel rund… Was Judentum, Christentum und Islam gemeinsam haben. Eine besondere Familiengeschichte.“ Erschienen im Tyrolia-Verlag.Montag, 08. September 2025Wir Gottgewollten.Röm 8, 28-30Dienstag, 09. September 2025Taufkraft.Kol 2, 6-15Mittwoch, 10. September 2025Die menschliche Bibel.Lk 6, 20-26Donnerstag, 11. September 2025Biblisch lieben.Kol 3, 12-17Freitag, 12. September 2025Die Lebensgeschichte als Geschenk.1 Tim 1, 1-2.12-14Samstag, 13. September 2025Warum wenig viel ist.Mk 4, 1-20Einen Link zu den Texten finden Sie hier.

Megyn Kelly is joined by Graham Linehan, comedy writer and co-creator of Father Ted, to discuss his recent arrest over a few posts on X about "trans" issues, the harassment he says he has faced from radical transgender activists, the personal toll taking a stand has taken on his life and career, the backsliding in the culture of free speech, the details surrounding his arrest, his decision to sue the police over the arrest, and more. Then Charlie Cooke and Rich Lowry of National Review join to discuss the horrifying stabbing of a young Ukrainian woman in Charlotte, the decision by the national media not to cover it, details about the incident and the repeat offender, shocking remarks made by the Charlotte mayor,  the hypocrisy of the media covering certain crimes but refusing to cover others like in Charlotte, the viral moment over a home run ball debacle at a Phillies game with a "Karen" fan, the unspoken rules behind this type of scenario, and more. Find more from Graham and support him here: https://grahamlinehan.substack.com/https://x.com/Glinner Cooke: https://x.com/charlescwcooke/Lowry: https://www.nationalreview.com/ Firecracker Farm: Visit https://firecracker.FARM & enter code MK at checkout for a special discount!All Family Pharmacy: Order now at https://allfamilypharmacy.com/MEGYN and save 10% with code MEGYN10Byrna: Go to https://Byrna.com or your local Sportsman's Warehouse today.Birch Gold: Text MK to 989898 and get your free info kit on gold  Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow

Dr. Pedro Barata and Dr. Rana McKay discuss the integration of innovative advances in molecular imaging and therapeutics to personalize treatment for patients with renal cell and urothelial carcinomas. TRANSCRIPT Dr. Pedro Barata: Hello, I'm Dr. Pedro Barata, your guest host of By the Book, a podcast series featuring insightful conversations between authors and editors of the ASCO Educational Book. I'm a medical oncologist at University Hospitals Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. Now, we all know the field of genitourinary cancers (GU) is evolving quite rapidly, and we have new innovations in molecular imaging as well as targeted therapeutics. Today's episode will be exploring novel approaches that are transforming the management of renal cell and urothelial carcinomas and also their potential to offer a more personalized treatment to patients. For that, joining for today's discussion is Dr. Rana McKay, a GU medical oncologist and professor at University of California San Diego. Dr. McKay will discuss her recently published article titled, “Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor-Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas.”  Our full disclosures are available in the transcript of this episode.  And with that, Rana McKay, great to have you on the podcast today. Dr. Rana McKay: Oh, thank you so much, Dr. Barata. It's really wonderful to be here with you. So, thanks for hosting. Dr. Pedro Barata: No, thanks for taking the time, and I'm looking forward to this conversation. And by the way, let me start by saying congrats on a great article in the Educational Book. Really super helpful paper. I'm recommending it to a lot of the residents and fellows at my own institution. I would like to first ask you to kind of give our listeners some context of how novel approaches in the molecular imaging as well as targeted therapeutics are actually changing the way we're managing patients with GU, but specifically with renal cell carcinoma and urothelial carcinoma. So, what are the areas you would call out as like being big areas for innovation in this context, and why are they important? Dr. Rana McKay: Very good question. And I think this is really what this article highlights. It highlights where are we going from an imaging diagnostics standpoint? Where are we going from a therapeutic standpoint? And I think if we have to step back, from the standpoint of diagnostics, we've seen PET imaging really transform diagnostics in prostate cancer with the advent of PSMA PET imaging, and now PSMA PET imaging is used as a biomarker for selection for theranostics therapy. And so, we're starting to see that enter into the RCC landscape, enter into the urothelial cancer landscape to a lesser extent. And I think it's going to potentially be transformative as these tools get more refined. I think when we think about therapeutics, what's been transformative most recently in the renal cell carcinoma landscape has been the advent of HIF2α inhibition to improve outcomes for patients. And we have seen the approval of belzutifan most recently that has reshaped the landscape. And now there's other HIF2α inhibitors that are being developed that are going to be further important as they get refined. And lastly, I think when we think about urothelial carcinoma, the greatest transformation to treatment in that context has been the displacement of cisplatin and platinum-based chemotherapy as a frontline standard with the combination of enfortumab vedotin plus pembrolizumab. And we've seen antibody-drug conjugates really reshape treatment and tremendously improve outcomes for patients. So, I think those are the three key areas of interest. Dr. Pedro Barata: So with that, let's focus first on the imaging and then we'll get to the therapeutic area. So, we know there's been a paradigm shift, really, when prostate-specific targets emerged as tracers for PET scanning. And so, we now commonly use prostate-specific membrane antigen, or PSMA-based PET scanning, and really transform how we manage prostate cancer. Now, it appears that we're kind of seeing a similar wave in renal cell carcinoma with the new radiotracer against the target carbonic anhydrase IX. What can you tell us about this? And is this going to be available to us anytime soon? And how do you think that might potentially change the way we're managing patients with RCC today? Dr. Rana McKay: First, I'll step back and say that in the context of PSMA PET imaging, we have actually been able to better understand RCC as well. So, we know that PSMA is expressed in the neovasculature of tumors, and it can actually be used to detect renal cell carcinoma tumors. It has a detection rate of about 84% when used for detection. And so, you know, I don't think it's just restricted to carbonic anhydrase IX, but we will talk about that. So, PSMA expressed in the neovasculature has a detection rate of around 84%, particularly if we're looking at clear cell RCC. CAlX is overexpressed in clear cell RCC, and it's actually used in diagnosing renal cell carcinoma when we think of CAlX IHC for diagnosing clear cell RCC. And now there are CAlX PET tracers. The first foray was with the ZIRCON study that was actually an interestingly designed study because it was designed to detect the likelihood of PET imaging to identify clear cell RCC. So, it was actually used in the early diagnostics setting when somebody presents with a renal mass to discriminate that renal mass from a clear cell versus a non-clear cell, and it was a positive study. But when I think about the potential application for these agents, you know, I think about the entire landscape of renal cell carcinoma. This is a disease that we do treat with metastasis-directed therapy. We have certainly seen patients who've undergone metastasectomy have long, durable remissions from such an approach. And I think if we can detect very early onset oligometastatic disease where a metastasis-directed therapy or SABR could be introduced - obviously tested in a trial to demonstrate its efficacy - I think it could potentially be transformative. Dr. Pedro Barata: Wonderful. It's a great summary, and I should highlight you are involved in some of those ongoing studies testing the performance of this specific PET scanning for RCC against conventional imaging, right? And to remind the listeners, thus far, for the most part, we don't really do FDG-PET for RCC. There are some specific cases we do, but in general, they're not a standard scanning. But maybe that will change in the future. Maybe RCC will have their own PSMA-PET. And to your point, there's also emerging data about the role of PSMA-PET scanning in RCC as well, as you very elegantly summarized. Wonderful. So, let me shift gears a little bit because you did, in your introduction, you did highlight a novel MOA that we have in renal cell carcinoma, approved for use, initially for VHL disease, and after that for sporadic clear cell renal cell carcinoma. We're talking about hypoxia-inducible factor 2-alpha inhibitors, or HIF2α inhibitors, such as belzutifan. But there's also others coming up. So, as a way to kind of summarize that, what can you tell us about this breakthrough in terms of therapeutic class, this MOA that got to our toolbox of options for patients with advanced RCC? Tell us a little bit what is being utilized currently in the management of advanced RCC. And where do you see the future going, as far as, is it moving early on? Is it getting monotherapy versus combinations? Maybe other therapies? What are your thoughts about that? What can you tell us about it? Dr. Rana McKay: Belzutifan is a first-in-class HIF2α inhibitor that really established clinical validation for HIF2α as a therapeutic target. When we think about the activity of this agent, the pivotal LITESPARK-005 trial really led to the approval of belzutifan in patients who were really heavily pretreated. It was patients who had received prior IO therapy, patients who had received prior VEGF-targeted therapy. And in the context of this study, we saw a median PFS of 5.6 months, and there did seem to be a tail on the curve when you looked at the 12-month PFS rate with belzutifan. It was 33.7% compared to 17.6% with everolimus. And then when we look at the response rate, it was higher with belzutifan on the order of 22-23%, and very low with everolimus, as we've previously seen. I think one of the Achilles heels of this regimen is the primary PD rate, which was 34% when used in later line. There are multiple studies that are testing belzutifan in combination across the treatment landscape. So, we have LITESPARK-011, which is looking at the combination of belzutifan plus lenvatinib in the second-line setting. We've got the MK-012 [LITESPARK-012] study, which is looking at belzutifan in various combinations in the frontline setting. So there is a combination with IO plus belzutifan. And so this is also being looked at in that context. And then we also have the LITESPARK-022 study, which is looking at pembrolizumab with belzutifan in the adjuvant setting. So there's a series of studies that will be exploring belzutifan really across the treatment landscape. Many of these studies in combination. Additionally, there are other HIF2α inhibitors that are being developed. We have casdatifan, which is another very potent HIF2α inhibitor. You know, I think pharmacologically, these are different agents. There's a different half-life, different dosing. What is going to be the recommended phase 3 dose for both agents, the EPO suppression levels, the degree of EPO suppression, and sustainability of EPO suppression is very different. So, I think we've seen data from casdatifan from the ARC-20 trial from monotherapy with a respectable response rate, over 30%, primary PD rate hovering just around 10%.  And then we've also seen data of the combination of casdatifan with cabozantinib as well that were recently presented this year. And that agent is also being tested across the spectrum of RCC. It's being looked at in combination with cabozantinib in the PEAK-1 study, and actually just at the KCRS (Kidney Cancer Research Summit), we saw the unveiling of the eVOLVE-RCC trial, which is going to be looking at a volrustomig, which is a PD-1/CTLA-4 inhibitor plus casdatifan compared to nivo-ipi in the frontline setting.  So, we're going to see some competition in this space of the HIF2α inhibitors. I think when we think of mechanism of action in that these are very potent, not a lot of off-target activity, and they target a driver mutation in the disease. And that driver mutation happens very early in the pathogenesis. These are going to be positioned much earlier in the treatment landscape. Dr. Pedro Barata: All these studies, as you're saying, look really promising. And when we talk about them, you mentioned a lot of combinations. And to me, when I think of these agents, it makes a lot of sense to combine because there's not a lot of overlapping toxicities, if you will. But perhaps for some of our listeners, who have not used HIF2α inhibitors in practice yet, and they might be thinking about that, what can you tell us about the safety profile? How do you present it to your patients, and how do you handle things like hypoxia or anemia? How do you walk through the safety profile and tolerability profile of those agents like belzutifan? Dr. Rana McKay: I think these drugs are very different than your traditional TKIs, and they don't cause the classic symptoms that are associated with traditional TKIs that many of us are very familiar with like the rash, hand-foot syndrome, hypertension, diarrhea. And honestly, these are very nuanced symptoms that patients really struggle with the chronicity of being on a chronic daily TKI. The three key side effects that I warn patients about with HIF2α inhibitors are: (1) fatigue; (2) anemia; and (3) hypoxia and dysregulation in the ability to sense oxygen levels. And so, many of these side effects - actually, all of them - are very dose-dependent. They can be very well-managed. So, we can start off with the anemia. I think it's critically important before you even start somebody on belzutifan that you are optimizing their hemoglobin and bone marrow function. Make sure they don't have an underlying iron deficiency anemia. Make sure they don't have B12 or folate deficiency. Check for these parameters. Many patients who have kidney cancer may have some hematuria, other things where there could be some low-level blood loss. So, make sure that those are resolved or you're at least addressing them and supplementing people appropriately. I monitor anemia very closely every 3 to 4 weeks, at least, when people start on these medications. And I do initiate EPO, erythropoietin, should the anemia start to worsen. And I typically use a threshold of around 10g/dL  for implementing utilization of an EPO agent, and that's been done very safely in the context of the early studies and phase 3 studies as well. Now, with regards to the hypoxia, I think it's also important to make sure that you're selecting the appropriate individual for this treatment. People who have underlying COPD, or even those individuals who have just a very high burden of disease in their lung, lymphangitic spread, pleural effusions, maybe they're already on oxygen - that's not an ideal candidate for belzutifan. Something that very easily can be done in the clinic before you think about initiating somebody on this treatment, and has certainly been integrated into some of the trials, is just a 6-minute walk test. You know, have the patient walk around the clinic with one of the MAs, one of the nurses, put the O2 sat on [measuring oxygen saturation], make sure they're doing okay. But these side effects, like I said, are very dose-dependent. Typically, if a patient requires, if the symptoms are severe, the therapy can be discontinued and dose reduced. The standing dose is 120 mg daily, and there's two dose reductions to 80 mg and 40 mg should somebody warrant that dose modification. Dr. Pedro Barata: This is relatively new, right? Like, it was not that we're used to checking oxygen levels, right? In general, we're treating these patients, so I certainly think there's a learning curve there, and some of the points that you highlight are truly critical. And I do share many of those as well in our practice. Since I have you, I want to make sure we touch base on antibody-drug conjugates as well. It's also been a hot area, a lot of developments there. When I think of urothelial carcinoma and renal cell carcinoma, I see it a little bit different. I think perhaps in urothelial carcinoma, antibody-drug conjugates, or ADCs, are somewhat established already. You already mentioned enfortumab vedotin. I might ask you to expand a little bit on that. And then in renal cell carcinoma, we have some ADCs as well that you include in your chapter, and that I would like you to tell us what's coming from that perspective. So, tell us a little bit about how do you see ADCs in general for GU tumors, particularly UC and RCC? Tell us a little bit about the complexity or perhaps the challenges you still see. At the same time, tell us about the successes. Dr. Rana McKay: Stepping back, let's just talk about like the principles and design of ADCs. So, most ADCs have three components. There's a monoclonal antibody that typically targets a cell surface antigen, which is conjugated by a linker, which is the second component, to a payload drug. And typically, that payload drug has been chemotherapy, whether it be topoisomerase or whether it be MMAE or other chemotherapeutic. We can start in the RCC space. There's been multiple antibody-drug conjugates that have been tested. There's antibody-drug conjugates to CD70, which is expressed on clear cell RCC. There's been antibody-drug conjugates to ENPP3, which is also expressed on RCC. There's antibody-drug conjugates to CDH6. And they have different payloads, like I said, whether it be topoisomerase I or other microtubule inhibitors. Now, when we think about kidney cancer, we don't treat this disease with chemotherapy. This disease is treated with immunotherapy. It is treated with treatments that target the VEGF pathway and historically has not been sensitive to chemo. So, I think even though the targets have been very exciting, we've seen very underwhelming data regarding activity, and in some context, seen increased toxicity with the ADCs. So, I think we need to tread lightly in the context of the integration and the testing of ADCs in RCC. We just came back from the KCRS meeting, and there was some very intriguing data about a c-Kit ADC that's being developed for chromophobe RCC, which is, you know, a huge unmet need, these variant tumors that really lack appropriate therapeutics. But I just caution us to tread lightly around how can we optimize the payload to make sure that the tumor that we're treating is actually sensitive to the agent that's targeting the cell kill. So, that's a little bit on the ADCs in RCC. I still think we have a long way to go and still in early testing. Now, ADCs for UC are now the standard of care. I think the prototypical agent, enfortumab vedotin, is a nectin-4-directed ADC that's conjugated to an MMAE payload and was the first ADC approved for advanced urothelial, received accelerated approval following the EV-201 trial, which was basically a multicenter, single-arm study that was investigating EV in cisplatin-ineligible patients with advanced urothelial carcinoma, and then ultimately confirmed in the EV-301 study as well. And so, that study ended up demonstrating the support superiority of EV from an overall survival standpoint, even PFS standpoint. Building on that backbone is the EV-302 study, which tested EV in combination with pembrolizumab versus platinum-based chemotherapy in the frontline setting. And that was a pivotal, landmark study that, like I said, has displaced platinum therapy as a frontline treatment for people with advanced urothelial carcinoma. And when we think about that study and the median overall survival and just how far we've come in urothelial cancer, the median OS with EV-pembro from that trial was 31 and a half months. I mean, that's just incredible. The control arm survival was 16 and a half months. The hazard ratio for OS, 0.47. I mean this is why when this data was presented, it was literally a standing ovation that lasted for several minutes because we just haven't seen data that have looked that good. And there are other antibody-drug conjugates that are being tested. We've all been involved in the saga with sacituzumab govitecan, which is a trophoblast cell surface antigen 2 (Trop-2) targeted ADC with a topoisomerase I payload. It was the second ADC to receive approval, but then that approval was subsequently withdrawn when the confirmatory phase 3 was negative, the TROPiCS-04 trial. So, approval was granted based off of the TROPHY-U-01, single-arm, phase 2 study, demonstrating a response rate of around 28% and a PFS of, you know, about 5 and a half months. But then failure to show any benefit from an OS standpoint. And I think there's a lot of controversy in the field around whether this agent still has a role in advanced urothelial carcinoma. And I think particularly for individuals who do not have molecular targets, like they're not HER2-amplified or have HER2-positivity or FGFR or other things like that. Dr. Pedro Barata: Fantastic summary, Rana. You were talking about the EV, and it came to mind that it might not be over, right, for the number of ADCs we use in clinical practice in the near future. I mean, we've seen very promising data for ADC against the HER2, right, and over-expression. It also can create some challenges, right, in the clinics because we're asking to test for HER2 expression. It's almost like, it's not exactly the same to do it in breast cancer, but it looks one more time that we're a little bit behind the breast cancer field in a lot of angles. And also has vedotin as a payload. Of course, I'm referring to disitamab vedotin, and there's very elegant data described by you in your review chapter as well. And it's going to be very interesting to see how we sequence the different ADCs, to your point as well. So, before we wrap it up, I just want to give you the opportunity to tell us if there's any area that we have not touched, any take-home points you'd like to bring up for our listeners before we call it a day. Dr. Rana McKay: Thank you so much. I have to say, you know, I was so excited at ASCO this year looking at the GU program. It was fantastic to see the progress being made, novel therapeutics that really there's a tremendous excitement about, not just in RCC and in UC, but also in prostate cancer, thinking about the integration of therapies, not just for people with refractory disease that, even though our goal is to improve survival, our likelihood of cure is low, but also thinking about how do we integrate these therapies early in the treatment landscape to enhance cure rates for patients, which is just really spectacular. We're seeing many of these agents move into the perioperative setting or in combination with radiation for localized disease. And then the special symposium on biomarkers, I mean, we've really come a long, long way. And I think that we're going to continue to evolve over the next several years. I'm super excited about where the field is going in the treatment of genitourinary malignancies. Dr. Pedro Barata: Oh, absolutely true. And I would say within the Annual Meeting, we have outstanding Educational Sessions. And just a reminder to the listeners that actually that's where the different teams or topics for the Educational Book chapters come from, from actually the educational sessions from ASCO. And your fantastic chapter is an example of that, right, focusing on advanced GU tumors. So, thank you so much, Rana, for taking the time, sharing your insights with us today on the podcast. It was a fantastic conversation as always. Dr. Rana McKay: My pleasure. Thanks so much for having me, Dr. Barata. Dr. Pedro Barata: Of course.  And thank you to our listeners for your time today. You will find the link to the article discussed today in the transcript of this episode. I also encourage you to check out the 2025 ASCO Educational Book. You'll find an incredible wealth of information there. It's free, available online, and you'll find, hopefully, super, super important information on the key science and issues that are shaping modern oncology, as we've heard from Dr. McKay and many other outstanding authors. So, thank you, everyone, and I hope to see you soon. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:        Dr. Pedro Barata @PBarataMD Dr. Rana McKay @DrRanaMcKay Follow ASCO on social media:        @ASCO on X (formerly Twitter)        ASCO on Bluesky       ASCO on Facebook        ASCO on LinkedIn        Disclosures:     Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck  Dr. Rana McKay: Consulting or Advisory Role: Janssen, Novartis, Tempus, Pfizer, Astellas Medivation, Dendreon, Bayer, Sanofi, Vividion, Calithera, Caris Life Sciences, Sorrento Therapeutics, AVEO, Seattle Genetics, Telix, Eli Lilly, Blue Earth Diagnostics, Ambrx, Sumitomo Pharma Oncology, Esiai, NeoMorph, Arcus Biosciences, Daiichi Sankyo, Exelixis, Bristol Myers Squibb, Merck, Astrazeneca, Myovant Research Funding (Inst.): Bayer, Tempus, AstraZeneca, Exelixis, Bristol Myers Squibb, Oncternal Therapeutics, Artera    

Подкаст «Top Club Chart» выходит каждый понедельник.  Подпишись на нас в Apple Podcasts, Castbox и SoundStream, чтобы не пропустить новые эпизоды.  Комментарии, вопросы и пожелания отправляй на t.bodrov@europaplus.ru  Ведущий и продюсер: Тимур Бодров Саундпродюсер: Ярослав Чернобров Редактор подкаста: Дарья Бельдий 1. Fantomel & Kate Linn - Dame Un Grrr (PROVI Remix) (25 место) 2. Calvin Harris ft. Clementine Douglas - Blessings (Cassian Remix) (24 место) 3. Shakedown - At Night (Anyma & Layton Giordani Remix) (23 место) 4. Rossi. & Jazzy - High On Me (22 место) 5. 3 Are Legend & Timbaland & W&W - Cry Me A River (21 место) 6. Disco Lines & Tinashe - No Broke Boys (20 место) 7. Empire Of The Sun - Walking On A Dream (BLOND:ISH Remix) (19 место) 8. Calvin Harris & D.O.D - Sweet Nothing (2025 Edit) (18 место) 9. Tommy Veanud - Summertime Sadness (РЕЗИДЕНЦИЯ) 10. MK ft. CHRYSTAL - Dior (17 место) 11. Alaia & Gallo - Lipstick (16 место) 12. Jordan Peak - Front 2 Back (15 место) 13. Camisra & James Hype - Let Me Show You (14 место) 14. Alexander Popov & Terry Golden - Obsession (13 место) 15. The Chemical Brothers - Galvanize (Chris Lake Remix) (12 место) 16. Argy & MEDUZA ft. PollyAnna - Melodia (11 место) 17. DumitrEscu - Sitting In The Sun (Walking In The Rain) (10 место) 18. Toman - Verano en NY (9 место) 19. Samm (BE) - Body Language (8 место) 20. FISHER & bbyclose – Blackberries (7 место) 21. Skytech & Vion Konger - Everybody's Free (To Feel Good) (6 место) 22. Dirty Vegas - Days Go By (ХИТ ВСЕХ ВРЕМЁН) 23. Mau P - TESLA (5 место) 24. Chris Lorenzo & Max Styler & Audio Bullys - London's On Fire (4 место) 25. Sebastian Ingrosso ft. Céline Dion - A New Day (3 место) 26. Jonas Blue & Malive - Edge Of Desire (2 место) 27. Paul Oakenfold & Goom Gum - The House Of House (ПЕРСПЕКТИВА) 28. CamelPhat & Elderbrook - Cola (ARTBAT Remix) (1 место)

No Man Shall Stand Against Me! | ഒരു മനുഷ്യനും എൻ്റെ നേരെ നിൽക്കയില്ല! | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1705 | 08 Sep 2025

1. Chris Lorenzo, Marco Strous & Buraka Som Sistema - BaBaBa (Hangover) (Extended Mix) 2. Fantomel, Kate Linn - Dame Un Grrr (Provi Extended Remix) 3. Nate Dogg & Kolter - Liquor Store (Extended Mix) 4. Vinter (BR) - Space Pump (Space Jam) (Extended Mix) 5. Calvin Harris & Jessie Reyez - Ocean (Extended Mix) 6. Röyksopp ft. Susanne Sundfør - Running to the Sea (anamē Remix) 7. James Hype - Waterfalls (Ash Edit Extended VIP) 8. Gorgon City - Loveless (George FitzGerald Extended Mix) 9. Sonny Fodera & Jazzy - All This Time (Chemikkal Remix Extended Mix) 10. MORTEN & David Guetta - Lucky (Extended Mix) 11. Odd Mob, OMNOM & HYPERBEAM - System (Extended Mix) 12. CamelPhat - Sunshine (John Cala Extended Remix) 13. Jamie Jones & Nicole Moudaber ft. House Of Molly - Where All My People (Extended Mix) 14. MK & Chrystal - Dior (Solardo Extended Remix) 15. D.O.D & Calvin Harris - Sweet Nothing (2025 Extended Edit) 16. Calvin Harris & Clementine Douglas - Blessings (Airwolf Paradise Extended Remix) 17. Kylie Minogue - Lights Camera Action (Zach Witness Remix)

Zdravo. Tokrat začnemo nostalgično: spomnimo se daljinca na kabel, prvih igralnih konzol iz konca 70-ih in 80-ih, ter (ker je september) študiramo, katere podkaste je najbolje poslušati v gneči na cesti. Iz te debate nas katapultira do drznega teološkega vprašanja, ali res obstaja bog prometnih kolon in ali ga slučajno častimo vsakič, ko hupamo. Ali pa hupanje deluje kot cerkveni zvon? Sveta Feltna ali Sveti Hupko, usmili se nas. Namesto nas najde rešitev za manj gneče Roman Mars, mi pa brainstormamo, kateri podkast najbolj pomirja na začetku kolone na Celovške, potem pa čudežno preidemo na 2. poglavje knjige Zadnja priložnost. Tri leta po dogodkih iz 1. poglavja so naši junaki na lovu za komodskim zmajem. Mi pa razmišljamo, zakaj so nam plazilci manj simpatični od kosmatih mesojedcev.

09. bis 13. September 2025 – 23. Woche im JahreskreisChristine Hubka macht sich Gedanken zu den Evangelien der Wochentage. Sie ist evangelische Pfarrerin im Ruhestand, Gefängnisseelsorgerin und Autorin. Unter ihren Büchern sind immer wieder auch Kinderbücher. Z.B.: „Und doch sind alle Äpfel rund… Was Judentum, Christentum und Islam gemeinsam haben. Eine besondere Familiengeschichte.“ Erschienen im Tyrolia-Verlag.Montag, 08. September 2025Wir Gottgewollten.Röm 8, 28-30Dienstag, 09. September 2025Taufkraft.Kol 2, 6-15Mittwoch, 10. September 2025Die menschliche Bibel.Lk 6, 20-26Donnerstag, 11. September 2025Biblisch lieben.Kol 3, 12-17Freitag, 12. September 2025Die Lebensgeschichte als Geschenk.1 Tim 1, 1-2.12-14Samstag, 13. September 2025Warum wenig viel ist.Mk 4, 1-20Einen Link zu den Texten finden Sie hier.

Reflections on Mk. 16:16 - Mk. 16:16

This week on the Toy Power Podcast; we are only a team of Three again. Unfortunately Scot is missing; but the show must go on! Keeping in the theme of 'Three' - that's exactly how many topics we have for you this Episode! Starting things off is a healthy chat around our Personal thoughts around: What it takes for a successful Crowdfunding Campaign. With Crowdfunding now the new norm; we review the past, present & future of this unique sales pitch option. Second Topic; is a Fun review of the New Lego Transformers Set - in the Form of Soundwave! Including his companion characters - Laserbeak & Ravage. This set really is impressive and the Sound Option is a welcomed point of difference too! Rounding out our Topics; is: 'State Of The Nation.' This is a Reality Check-in for us; to access our Collecting Journey and take note of our future plans. It turns into a bit of a therapy session, as we each give advise to one-another on assessment of our very addictive Toy Collecting Habits!! This honestly was a really fun episode as we get quite personal; and share a lot of our own distinctive opinions.Support the show: http://patreon.com/toypowerpodcastSee omnystudio.com/listener for privacy information.

Msgr. Roger J. Landry St. Patrick’s Church, Bedford, NY Baptism of Nicholas Patrick Perez-Benzo September 6, 2025 Ezek 47:1-9.12, Ps 34, Eph 4:1-6, Mk 1:9-11 To listen to an audio recording of today’s homily, please click below:  https://traffic.libsyn.com/secure/catholicpreaching/9.6.25_Baptism_of_Nicholas_Patrick_Perez_Benzo_1.mp3   The readings for today’s Mass were:  A Reading from the Book of the Prophet Ezekiel Then […] The post Homily for the Baptism of Nicholas Patrick Perez-Benzo, St. Patrick Church, Bedford, NY, September 6, 2025 appeared first on Catholic Preaching.

The Royal Saving Power | രക്ഷയുടെ രാജകീയ ശക്തി | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1704 | 06 Sep 2025

Jesus Heals a Man with a Demon5 They came to the other side of the sea, to the country of the Gerasenes. 2 And when Jesus had stepped out of the boat, immediately there met him out of the tombs a man with an unclean spirit. 3 He lived among the tombs. And no one could bind him anymore, not even with a chain, 4 for he had often been bound with shackles and chains, but he wrenched the chains apart, and he broke the shackles in pieces. No one had the strength to subdue him. 5 Night and day among the tombs and on the mountains he was always crying out and cutting himself with stones. 6 And when he saw Jesus from afar, he ran and fell down before him. 7 And crying out with a loud voice, he said, “What have you to do with me, Jesus, Son of the Most High God? I adjure you by God, do not torment me.” 8 For he was saying to him, “Come out of the man, you unclean spirit!” 9 And Jesus asked him, “What is your name?” He replied, “My name is Legion, for we are many.” 10 And he begged him earnestly not to send them out of the country. 11 Now a great herd of pigs was feeding there on the hillside, 12 and they begged him, saying, “Send us to the pigs; let us enter them.” 13 So he gave them permission. And the unclean spirits came out and entered the pigs; and the herd, numbering about two thousand, rushed down the steep bank into the sea and drowned in the sea. 14 The herdsmen fled and told it in the city and in the country. And people came to see what it was that had happened. 15 And they came to Jesus and saw the demon-possessed man, the one who had had the legion, sitting there, clothed and in his right mind, and they were afraid. 16 And those who had seen it described to them what had happened to the demon-possessed man and to the pigs. 17 And they began to beg Jesus to depart from their region. 18 As he was getting into the boat, the man who had been possessed with demons begged him that he might be with him. 19 And he did not permit him but said to him, “Go home to your friends and tell them how much the Lord has done for you, and how he has had mercy on you.” 20 And he went away and began to proclaim in the Decapolis how much Jesus had done for him, and everyone marveled. Jesus Heals a Woman and Jairus's Daughter21 And when Jesus had crossed again in the boat to the other side, a great crowd gathered about him, and he was beside the sea. 22 Then came one of the rulers of the synagogue, Jairus by name, and seeing him, he fell at his feet 23 and implored him earnestly, saying, “My little daughter is at the point of death. Come and lay your hands on her, so that she may be made well and live.” 24 And he went with him. And a great crowd followed him and thronged about him. 25 And there was a woman who had had a discharge of blood for twelve years, 26 and who had suffered much under many physicians, and had spent all that she had, and was no better but rather grew worse. 27 She had heard the reports about Jesus and came up behind him in the crowd and touched his garment. 28 For she said, “If I touch even his garments, I will be made well.” 29 And immediately the flow of blood dried up, and she felt in her body that she was healed of her disease. 30 And Jesus, perceiving in himself that power had gone out from him, immediately turned about in the crowd and said, “Who touched my garments?” 31 And his disciples said to him, “You see the crowd pressing around you, and yet you say, ‘Who touched me?' ” 32 And he looked around to see who had done it. 33 But the woman, knowing what had happened to her, came in fear and trembling and fell down before him and told him the whole truth. 34 And he said to her, “Daughter, your faith has made you well; go in peace, and be healed of your disease.” 35 While he was still speaking, there came from the ruler's house some who said, “Your daughter is dead. Why trouble the Teacher any further?” 36 But overhearing what they said, Jesus said to the ruler of the synagogue, “Do not fear, only believe.” 37 And he allowed no one to follow him except Peter and James and John the brother of James. 38 They came to the house of the ruler of the synagogue, and Jesus saw a commotion, people weeping and wailing loudly. 39 And when he had entered, he said to them, “Why are you making a commotion and weeping? The child is not dead but sleeping.” 40 And they laughed at him. But he put them all outside and took the child's father and mother and those who were with him and went in where the child was. 41 Taking her by the hand he said to her, “Talitha cumi,” which means, “Little girl, I say to you, arise.” 42 And immediately the girl got up and began walking (for she was twelve years of age), and they were immediately overcome with amazement. 43 And he strictly charged them that no one should know this, and told them to give her something to eat. The Holy Bible: English Standard Version (Wheaton, IL: Crossway Bibles, 2016), Mk 5:1–43.

One hour of hand picked selections from house music maestro and remix extraordinaire, MK! Expect fresh cuts and upcoming releases from himself, his record label, favourite producers and DJ friends. Delving in to house and techno, new and old, as well as showcasing his Track Of The Month, AREA10 Fire, From The Vault and exclusive Guest Mix each month. This is AREA10 ON AIR! Secluded Family - What Have You Done (Tough Love Remix)Josh Baker feat. Poppy Wright & Trick Shady - Leave A Message (Instrumental) [BAKERS DOZEN]Huxley - Terraform (Extended Mix) [Electronic Nature Records]FunkFuse - The Mess - Modern Delivery XpressCarl Waller - Who Do You Love [Pitch Records]Adam Ten, Rafael - Sweet Boy (Extended Mix) [Maccabi House]Alexander Som - Paddingtone (PRX005) - Process RecordsEjeca & Danny Howard - Dreams - Factory 93ALESHA DIXON - Chargie (JESS BAYS REMIX) #ToughLovesToughJamSebastian Ledher feat. Nakary - NastyMPH - Until The Morning (Extended Mix)Jamie Jones & Nicole Moudaber ft. House Of Molly - Where All My PeopleZack Darza - Like a Pro (Extended)Balanka - Fatal Blows - Repopulate MarsCastion - Fall Out The Beat - SolaOmar Ft Stevie Wonder - I'm Feeling You (Henrik Schwarz Remix) #ToughLovesTimeMachine

The Horn Of Salvation | രക്ഷയുടെ കൊമ്പ് | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1703 | 05 Sep 20252025

Bon Iver & Mk.gee at the Spaniel (Reagle Beagle?); dogs on the elevator; expert word writer; Godzilla not in Japan; fender bender lawyers; mailbox vs fire ants mound fireworks; Denver amusement park run by teenagers; Final Destination roller coasters.Unlock the BONUS SCENE(S) at improv4humans.com and gain access to every episode of i4h, all ad-free, as well as TONS of exclusive new podcasts delving deeper into improv, the history of comedy, music and sci-fi.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

SEP. 3, 2025How your faith can produce results (3)"In the same way, faith by itself, if it is not accompanied by action, is dead." Jas 2:17 NIVJames asks, "What good is it...if someone claims to have faith but has no deeds…Suppose a brother or a sister is without clothes and daily food. If one of you says...'Go in peace; keep warm and well fed, but does nothing...what good is it? In the same way, faith by itself, if it is not accompanied by action, is dead. But someone will say, 'You have faith; I have deeds' Show me your faith without deeds, and I will show you my faith by my deeds" (vv.14-18 NIV). A veritable ocean of faith without the appropriate action to follow it up is nothing more than an ocean of dead, useless faith. On the other hand, an ounce of faith that's acted upon can produce an ocean of results (See Mt 13:31-32). Action breathes life and power into your faith. The biblical prescription for faith is simple but potent. (1) You decide to believe in God's promise and His power to make it happen— leaving the "how and when" up to Him. (2) You choose to act in keeping with what you believe before you see any evidence of the results. (3) God responds to your faith by keeping His unbreakable promise. "Hath he said, and shall he not do it? or hath he spoken, and shall he not make it good?" (Nu 23:19). God goes to work exercising His unlimited capacity to perform His Word. Jesus said, "Whatever you ask for in prayer, believe that you have received it, and it will be yours" (Mk 11:24 NIV). Now—it's up to you to claim and act on His promise.How your faith can produce results Action breathes life and power into your faith.Share This DevotionalSend us a textSupport the showChanging Lives | Building Strong Family | Impacting Our Community For Jesus Christ!

The Rising Sun From Heaven | സ്വർഗത്തിൽ നിന്ന് സൂര്യോദയം | Malayalam Christian Messages | Br. Damien Antony | Morning Glory Podcast - 1702 | 04 Sep 20252025

Cộng đồng địa phương, cho biết một cuộc khủng hoảng môi trường đang diễn ra dọc biên giới Thái Lan - Myanmar, nơi nồng độ asen hay thạch tín cao nguy hiểm, đã được phát hiện trong một số con sông lớn. Hiện nay ngày càng có nhiều bằng chứng cho thấy, sự gia tăng khai thác đất hiếm không được kiểm soát ở bang Shan, miền Nam Myanmar là nguyên nhân. Và giờ đây khi ô nhiễm đã lan đến sông Mê Kông, các nhà môi trường cho rằng tác động có thể lan rộng khắp Đông Nam Á.

In this episode of the Real Estate Pros podcast, host Q Edmonds interviews MK Shadman, a passionate advocate for affordable housing solutions. MK shares her mission to provide housing for underserved populations, particularly focusing on urban and suburban areas in California. She discusses the challenges of funding and the need for innovative solutions to support the unsheltered community, including partnerships with various organizations. MK emphasizes the importance of empowering the younger generation, especially foster children, and calls for real estate professionals to engage in meaningful community support.   Professional Real Estate Investors - How we can help you: Investor Fuel Mastermind:  Learn more about the Investor Fuel Mastermind, including 100% deal financing, massive discounts from vendors and sponsors you're already using, our world class community of over 150 members, and SO much more here: http://www.investorfuel.com/apply   Investor Machine Marketing Partnership:  Are you looking for consistent, high quality lead generation? Investor Machine is America's #1 lead generation service professional investors. Investor Machine provides true ‘white glove' support to help you build the perfect marketing plan, then we'll execute it for you…talking and working together on an ongoing basis to help you hit YOUR goals! Learn more here: http://www.investormachine.com   Coaching with Mike Hambright:  Interested in 1 on 1 coaching with Mike Hambright? Mike coaches entrepreneurs looking to level up, build coaching or service based businesses (Mike runs multiple 7 and 8 figure a year businesses), building a coaching program and more. Learn more here: https://investorfuel.com/coachingwithmike   Attend a Vacation/Mastermind Retreat with Mike Hambright: Interested in joining a “mini-mastermind” with Mike and his private clients on an upcoming “Retreat”, either at locations like Cabo San Lucas, Napa, Park City ski trip, Yellowstone, or even at Mike's East Texas “Big H Ranch”? Learn more here: http://www.investorfuel.com/retreat   Property Insurance: Join the largest and most investor friendly property insurance provider in 2 minutes. Free to join, and insure all your flips and rentals within minutes! There is NO easier insurance provider on the planet (turn insurance on or off in 1 minute without talking to anyone!), and there's no 15-30% agent mark up through this platform!  Register here: https://myinvestorinsurance.com/   New Real Estate Investors - How we can work together: Investor Fuel Club (Coaching and Deal Partner Community): Looking to kickstart your real estate investing career? Join our one of a kind Coaching Community, Investor Fuel Club, where you'll get trained by some of the best real estate investors in America, and partner with them on deals! You don't need $ for deals…we'll partner with you and hold your hand along the way! Learn More here: http://www.investorfuel.com/club   —--------------------

Thank you, friends, for clicking on this episode of the Pondering Purple podcast, a source of information, insight and inspiration for those who love MKs and those who are MKs.···This episode is based on an article by the same name, which is available HERE....The Amazon page for Piece of Purple is HERE. For bulk order pricing of ten copies or me, please CONTACT me....More of my MK-related resources can be found at the following links:1. My most-read articles listed on my⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠website⁠⁠⁠⁠⁠⁠⁠⁠. 2. My grand new book--everything I've ever taught about MKs in one place--⁠Pieces of Purple⁠!3. My ⁠⁠⁠⁠⁠⁠⁠⁠playlist⁠⁠⁠⁠⁠⁠⁠⁠ of video "nuggets" on Youtube.4. My novel about a missionary family, ⁠⁠⁠⁠⁠⁠⁠⁠Of Stillness and Storm⁠⁠⁠⁠⁠⁠⁠⁠.···Four ways to make sure you don't miss an episode:1. Click subscribe after you find Pondering Purple on the podcast platform of your choice.2. Friend and follow me on ⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠--I'll announce new episodes as they release. (Make sure you hit "Follow first" under the "Follow" tab.)3. Join ⁠⁠⁠⁠⁠⁠⁠⁠The MK Hub⁠⁠⁠⁠⁠⁠⁠⁠, a group on Facebook solely devoted to sharing new materials as I produce them.4. Receive email notifications by writing “subscribe to podcast” in the subject line of a message you send to ⁠⁠⁠⁠⁠⁠⁠⁠shellphoenix@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠. (I promise--that's all you'll receive. No newsy epistles or cat pictures!)···Please share this resource in your missionary, MK, and TCK circles. I'd love it if you also left a comment on whatever platform you use, so Pondering Purple can be less of a monologue and more of a conversation.···The title of the podcast is a nod to the complex, beautiful, sometimes confounding, always life-shaping and ideally life-enhancing effects of growing up in the color swirl of cultures and worlds.···Helpful definitions:· MK or Missionaries' Kid - the child of missionaries.· TCK or Third Culture Kid - someone who has spent a majority of his/her formative years in a culture other than his/her passport culture. This includes missionaries' kids, military kids, business kids, diplomats' kids, etc.

Joe Sheehan, The Joe Sheehan Newsletter tells Ian why Mariners fans should be excited about September and the postseason chances they have this year. Joe sees the Mariners as extremely dangerous once they get into the playoffs. The most important thing about the postseason is getting the bye and also, home and away just doesn't really matter. Joe breaks down the AL West down the stretch. Should we be worried about Cal Raleigh? Cougar Roundtable! Alex Brink and Mkristo Bruce tell Ian what they saw from the Washington State football team, through the pluses and the minuses. How surprising was the quarterbacking situation and what does it mean going forward? Coug talk continues with Alex and MK who help us break down the defense we saw on Saturday.John Lund, Unleashed! John joins us from the Bay Area as we are highly anticipating the Seahawks hosting the 49ers this weekend. Per usual, Lund has plenty to say about 'hate week'. He tells us Seattle is still the true number one rivalry for Santa Clara. You also get the most entertaining and honest trash talk of the week. We check your text and kick off the first Fact or Fiction pick of the week, and finally, talk to Softy.See omnystudio.com/listener for privacy information.

Happy Labor Day Weekend listeners! Today on the show we'll talk about Destination D23, construction work on the Rivers of America at MK, the Muppets take over of Rock ‘n' Roller Coaster, and Email Time. Sit back, relax, and enjoy this week's episode of DW:60.

Megyn Kelly is joined by MK True Crime contributor Phil Holloway and Will Chamberlain of the Article III Project to discuss President Trump's massive legal victory as the civil fraud judgment of $500 million was thrown out on appeal, Letitia James' failed attempt to make good on her lawfare threats, Trump's latest statement celebrating his massive legal victory over Letitia James, whether Letitia James could be disbarred next, and more. Then Maureen Callahan, host of “The Nerve,” joins to discuss the latest details on Bryan Kohberger's prison complaints, his claims that he's being sexually harassed and that he can't sleep, what we're learning now about all the signs of his creepiness at his college, CNN's trash new “documentary” about JFK Jr. trying to rewrite the real narrative, the lies that are being told to try to prop up the Kennedys, Jennifer Aniston's Vanity Fair profile in which she complains about fame and attention, the bizarre details about her weekly dinners with Jimmy Kimmel and Jason Bateman, her new boyfriend is a self-help "guru" and professional hypnotist, the new Netflix documentary about the reality show “The Biggest Loser,” Maureen's expose on what went on behind the scenes, the exploitative nature of reality TV, the much-needed end to "Sex and the City" and its spin-offs, and more.  Subscribe to Maureen's show The Nerve:Apple: https://podcasts.apple.com/us/podcast/the-nerve-with-maureen-callahan/id1808684702Spotify: https://open.spotify.com/show/4kR07GQGQAJaMNtLc9Cg2oYouTube: https://www.youtube.com/@thenerveshow?sub_confirmation=1  Subscribe to MK True Crime:Apple: https://podcasts.apple.com/us/podcast/mk-true-crime/id1829831499Spotify: https://open.spotify.com/show/4o80I2RSC2NvY51TIaKkJWYouTube: https://www.youtube.com/@MKTrueCrime?sub_confirmation=1Social: http://mktruecrime.com/  Grand Canyon University: https://GCU.eduFirecracker Farm: Visit https://firecracker.FARM & enter code MK at checkout for a special discount!Done with Debt: https://www.DoneWithDebt.com & tell them Megyn Kelly sent you!Just Thrive: Visit https://justthrivehealth.com/discount/Megyn and use code MEGYN to save 20% sitewide Follow The Megyn Kelly Show on all social platforms:YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at:https://www.devilmaycaremedia.com/megynkellyshow